CoChat
Sign Up
Cited by 914Stress Responses and CortisolNeuropeptides and Animal PhysiologyNeuroendocrine regulation and behavior

The DOI matches its Crossref record; 643 of the 656 references it cites were found in a registry or an index.

Neuroendocrine pharmacology of stress

Carrasco, Gonzalo A, Van de Kar, Louis D·2003·European Journal of Pharmacology
DOI 10.1016/s0014-2999(03)01285-8
Open this paper in CoChat — free account

Abstract

Exposure to hostile conditions initiates responses organized to enhance the probability of survival. These coordinated responses, known as stress responses, are composed of alterations in behavior, autonomic function and the secretion of multiple hormones. The activation of the renin-angiotensin system and the hypothalamic-pituitary-adrenocortical axis plays a pivotal role in the stress response. Neuroendocrine components activated by stressors include the increased secretion of epinephrine and norepinephrine from the sympathetic nervous system and adrenal medulla, the release of corticotropin-releasing factor (CRF) and vasopressin from parvicellular neurons into the portal circulation, and seconds later, the secretion of pituitary adrenocorticotropin (ACTH), leading to secretion of glucocorticoids by the adrenal gland. Corticotropin-releasing factor coordinates the endocrine, autonomic, behavioral and immune responses to stress and also acts as a neurotransmitter or neuromodulator in the amygdala, dorsal raphe nucleus, hippocampus and locus coeruleus, to integrate brain multi-system responses to stress. This review discussed the role of classical mediators of the stress response, such as corticotropin-releasing factor, vasopressin, serotonin (5-hydroxytryptamine or 5-HT) and catecholamines. Also discussed are the roles of other neuropeptides/neuromodulators involved in the stress response that have previously received little attention, such as substance P, vasoactive intestinal polypeptide, neuropeptide Y and cholecystokinin. Anxiolytic drugs of the benzodiazepine class and other drugs that affect catecholamine, GABA(A), histamine and serotonin receptors have been used to attenuate the neuroendocrine response to stressors. The neuroendocrine information for these drugs is still incomplete; however, they are a new class of potential antidepressant and anxiolytic drugs that offer new therapeutic approaches to treating anxiety disorders. The studies described in this review suggest that multiple brain mechanisms are responsible for the regulation of each hormone and that not all hormones are regulated by the same neural circuits. In particular, the renin-angiotensin system seems to be regulated by different brain mechanisms than the hypothalamic-pituitary-adrenal system. This could be an important survival mechanism to ensure that dysfunction of one neurotransmitter system will not endanger the appropriate secretion of hormones during exposure to adverse conditions. The measurement of several hormones to examine the mechanisms underlying the stress response and the effects of drugs and lesions on these responses can provide insight into the nature and location of brain circuits and neurotransmitter receptors involved in anxiety and stress.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0014-2999(03)01285-8

Cites

643 of 643 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 656 references

Research works printed but not linked: 8

  1. Dahlstrom, 1965, Evidence for the existence of monoamine-containing neurons in the central nervous system IV, Acta Physiol. Scand., 64, 1
  2. Deak, 1999, The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress, Endocrinology, 140, 79, 10.1210/en.140.1.79 · DOI · Paper page
  3. Lorens, 1986, The serotonin antagonist LY53857, the 5-HT agonist 8-OH-DPAT, and intra-midbrain raphe, 5,7-dihidroxytryptamine lesions do not affect condiytioned fear induced increased in rennin secretion, Soc. Neurosci. Abstr., 12, 213
  4. Parsons, 1996, Extracellular serotonin is decreased in the nucleus accumbens during withdrawal from cocaine self-administration, Behav. Brain Res., 73, 225, 10.1016/0166-4328(96)00101-5 · DOI
  5. Santarelli, 2001, Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function, Proc. Natl. Acad. Sc. U. S. A., 98, 1912, 10.1073/pnas.041596398 · DOI
  6. Van Megen, 1997, Effect of the selective serotonin reuptake inhibitor fluvoxamine on CCK-4 induced panic attacks, Psychopharmacology (Berl.), 129, 357, 10.1007/s002130050201 · DOI
  7. Wank, 1995, Chosystokinin receptors, Am. J. Physiol., 269, G628
  8. Zhang, 2001, Co-localization of 5-HT1A and 5-HT2A serotonin receptors on oxytocin cells in the hypothalamic paraventricular nucleus, Neurosci. Abstr., 17, 136

Cited by

Sorted by citations

Items 801–900 of 910

Related

See all

Metadata

Authors
Carrasco, G. A., & Van de Kar, L. D.
Affiliations
Loyola University Chicago (US)
ORCID
Carrasco, Gonzalo A
Venue
European Journal of Pharmacology
Publisher
Elsevier BV
Published
2003-02
Volume
463
Issue
1-3
Pages
235-272
ISSN
0014-2999 (ISSN-L)
DOI
10.1016/s0014-2999(03)01285-8
OpenAlex
W1971277989
Cited by
914
References
656
Citations by year
2026: 7 · 2025: 11 · 2024: 24 · 2023: 27 · 2022: 29 · 2021: 37 · 2020: 32 · 2019: 30 · 2018: 36 · 2017: 27 · 2016: 36 · 2015: 34 · 2014: 43 · 2013: 64 · 2012: 49
FWCI
21.36
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • European Journal of Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute on Drug Abuse (R01DA013669, DA 13669)
  • National Institute of Neurological Disorders and Stroke (NS34153)
Topics
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
Keywords
stress response, neuroendocrine regulation, corticotropin-releasing factor, vasopressin, renin-angiotensin system, hypothalamic-pituitary-adrenal axis, catecholamines, serotonin, substance P, vasoactive intestinal peptide, neuropeptide Y, cholecystokinin, benzodiazepines, anxiolytics, antidepressants, anxiety disorders, glucocorticoids, ACTH, sympathetic nervous system, adrenal medulla
MeSH terms
Amygdala, Animals, Brain Chemistry, Endocrine System, Humans, Hypothalamus, Neurosecretory Systems, Stress, Physiological, Neurotransmitter Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review